Back to Feed
ClinicalTrials.gov|Clinical Trial
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease
Royan Institute
Abstract
Dopason is a phase I, open-label, multicenter, single-arm clinical trial designed to evaluate the safety and feasibility of intraputaminal transplantation of human embryonic stem cell-derived dopaminergic progenitor cells (DopaCells) in patients with moderately severe Parkinson's disease. Phase: PHASE1 Status: RECRUITING Conditions: Parkinson Disease (PD) Interventions: Dopacell; Immunosuppressive Regimen; Customized microinjection device
Keywords
Parkinson Disease (PD)